or Try an Advanced Search...

    Bone Disease Stocks List

    Symbol Grade Name % Change
    KROS A Keros Therapeutics, Inc. 3.27
    SMLR C Semler Scientific, Inc. 4.42
    AMGN C Amgen Inc. -0.29
    PROF F Profound Medical Corp. 1.10
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Medical Appliances & Equipment
    Related Stock Lists: Bone Medicine Hematology Organ Systems Prostate Cancer Therapeutic Products Ablation Anemia Biopharmaceutical Biotechnology Blood Cells Cancer Care Cardiovascular Disease Chronic Disease Clinic Clinical Medicine Diabetes Dialysis Disability Disease

    Related ETFs - A few ETFs which own one or more of the above listed Bone Disease stocks.

    Symbol Grade Name Weight
    BBH D Market Vectors Biotech ETF 16.72
    HRTS D Tema Cardiovascular and Metabolic ETF 9.83
    BIS C ProShares UltraShort Nasdaq Biotechnology 8.14
    IBBQ D Invesco Nasdaq Biotechnology ETF 8.1
    IBB C iShares Nasdaq Biotechnology Index Fund 7.84
    View all Bone Disease ETFs...
    Compare ETFs
    Compare BIS to IBBQ Compare HRTS to IBB Compare HRTS to IBBQ

        Bone Disease Stocks Recent News

        Date Stock Title
        Nov 1 AMGN Amgen Third Quarter 2024 Earnings: EPS Beats Expectations
        Oct 31 AMGN Amgen earns higher revenues in Q3 2024, puts rare diseases in the spotlight
        Oct 31 AMGN Q3 2024 Amgen Inc Earnings Call
        Oct 31 AMGN Amgen 'Laser-Focused' On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFO
        Oct 31 AMGN Amgen Q3 Earnings Beat, Sales In Line, Obesity Candidate in Focus
        Oct 31 AMGN Amgen Inc (AMGN) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Pipeline ...
        Oct 31 AMGN Amgen Inc. (AMGN) Q3 2024 Earnings Call Transcript
        Oct 31 AMGN Amgen Inc. 2024 Q3 - Results - Earnings Call Presentation
        Oct 31 AMGN Amgen (AMGN) Q3 2024 Earnings Call Transcript
        Oct 30 AMGN Amgen updates 2024 guidance with revenue and EPS ranges including consensus
        Oct 30 AMGN Compared to Estimates, Amgen (AMGN) Q3 Earnings: A Look at Key Metrics
        Oct 30 AMGN Amgen (AMGN) Beats Q3 Earnings Estimates
        Oct 30 AMGN Amgen in charts: Prolia, XGEVA sales gain, while Enbrel continues to wind down in Q3
        Oct 30 AMGN Amgen: Q3 Earnings Snapshot
        Oct 30 AMGN Amgen Non-GAAP EPS of $5.58 beats by $0.47, revenue of $8.5B in-line
        Oct 30 AMGN Amgen posts higher profit, obesity data on track for late this year
        Oct 30 AMGN AMGEN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
        Oct 29 AMGN Amgen Q3 2024 Earnings Preview: All eyes on obesity candidate data
        Oct 29 AMGN Pfizer Unveils Its Next Black Box In Obesity. It's Taking On Amgen.
        Oct 29 AMGN Amgen Inc. (NASDAQ:AMGN) is a favorite amongst institutional investors who own 79%
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Medical Appliances & Equipment
        Related Stock Lists: Bone Medicine Hematology Organ Systems Prostate Cancer Therapeutic Products Ablation Anemia Biopharmaceutical Biotechnology Blood Cells Cancer Care Cardiovascular Disease Chronic Disease Clinic Clinical Medicine Diabetes Dialysis Disability Disease
        Bone Disease

        Bone disease refers to the medical conditions which affect the bone.

        More about Bone Disease
        Browse All Tags